Paragraph 2 F1
A statement describing the types of investigational medicinal product in respect of which the authorisation is required, including their pharmaceutical forms F2and whether any of them is an MM investigational medicinal product or a POC investigational medicinal product.
Annotations
Textual amendments
- F1
Sch. 6 para. 2 substituted (29.8.2006) by The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 (S.I. 2006/1928), regs. 1(1), 31(a)
- F2
Words in Sch. 6 para. 2 inserted (23.7.2025) by The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025 (S.I. 2025/87), regs. 1(2), 51(2)